IL1B and Sepsis: More than 100 clinical trials have been conducted on more than 100 biological agents, including tumor necrosis factor (TNF) and interleukin-1 (IL-1) inhibitors, for the treatment of sepsis, but no specific drugs have been found at present [5, 6].